Osmotic diuresis.
Lang F.
Ren Physiol. 1987;10(3-4):160-73. doi: 10.1159/000173127.
Blood Pressure Lowering and Sodium-Glucose Co-transporter 2 Inhibitors (SGLT2is): More Than Osmotic Diuresis.
Sternlicht H, Bakris GL.
Curr Hypertens Rep. 2019 Feb 12;21(2):12. doi: 10.1007/s11906-019-0920-4.
Osmotic diuresis in chronic kidney disease: its significance and clinical utility.
Musso CG, Juarez R, Terrasa S, Gonzalez-Torres H, Aroca-Martinez G.
Int Urol Nephrol. 2019 Aug;51(8):1403-1406. doi: 10.1007/s11255-019-02202-5. Epub 2019 Jun 18.
Osmotic diuresis in diabetes insipidus.
BRODSKY WA, RAPOPORT S.
J Clin Invest. 1950 Jun;29(6):799.
Osmotic diuresis by SGLT2 inhibition stimulates vasopressin-induced water reabsorption to maintain body fluid volume.
Masuda T, Muto S, Fukuda K, Watanabe M, Ohara K, Koepsell H, Vallon V, Nagata D.
Physiol Rep. 2020 Jan;8(2):e14360. doi: 10.14814/phy2.14360.
Management of plasma hypertonicity resulting from osmotic diuresis.
Roumelioti ME, Tzamaloukas AH.
Int Urol Nephrol. 2019 Jun;51(6):1079-1080. doi: 10.1007/s11255-019-02137-x. Epub 2019 May 16.
Osmotic diuresis due to urea as the cause of hypernatraemia in critically ill patients.
Lindner G, Schwarz C, Funk GC.
Nephrol Dial Transplant. 2012 Mar;27(3):962-7. doi: 10.1093/ndt/gfr428. Epub 2011 Aug 2.
Osmotic diuresis-induced hypernatremia: better explained by solute-free water clearance or electrolyte-free water clearance?
Popli S, Tzamaloukas AH, Ing TS.
Int Urol Nephrol. 2014 Jan;46(1):207-10. doi: 10.1007/s11255-012-0353-3. Epub 2013 Jan 20.
Osmotic diuresis with SGLT2 inhibition: analysis of events related to volume reduction in dapagliflozin clinical trials.
Johnsson K, Johnsson E, Mansfield TA, Yavin Y, Ptaszynska A, Parikh SJ.
Postgrad Med. 2016 May;128(4):346-55. doi: 10.1080/00325481.2016.1153941. Epub 2016 Mar 2.
[Osmotic diuresis].
ORBACH-ARBOUYS S.
Ann Chir. 1961 Mar;15:317-9.
